Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth, and economic issues that impacted its ...

Medtronic (NYSE: MDT) + announced today that the FDA accepted its new Nellcor technology into its STeP program. The FDA Safer Technologies Program (STeP), a collaborative program, helps reduce the ...

Mother’s Day occurs every year in early May, coinciding with Women’s Health Month. In light of the two annual observances, Medtronic decided the timing was right to launch its Letter to My Mother ...

Upgrading Medtronic to 'Strong Buy' with a $104 fair ... The Diabetes business manufactures insulin pumps, sensors, continuous glucose monitoring (CGM) system and infusion sets for the management ...

Augustine, along with other large cities throughout the U.S., like New Orleans, Houston and Los Angeles. But Miami’s Little Havana truly adopted the birds as a symbol in 2002 when 6-foot (2-meter) ...

to enhance focus on high-margin growth drivers for Medtronic and accelerate innovation for the new entity. The diabetes unit, which manufactures insulin pumps and other wearable devices ...

Medtronic plc (NYSE:MDT) Q4 2025 Earnings Call Transcript May 21, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.62, expectations were $1.58. Operator: Good morning. I'm Ryan ...

He added that the change should give the diabetes business the funding and focus it needs to reach its full potential, and allow Medtronic to focus on other high-margin businesses, such as pulsed ...

Image credit: JHVEPhoto / Shutterstock.com Medtronic has announced plans to separate out its diabetes business into a new standalone company. The separation will serve to create an “independent, ...

The Medtronic Prevail drug coated balloon [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark for several expanded indications for its Prevail balloon ...